Dynamo-diabetes in youth and young adults of the pacific northwest

The Centers for Disease Control and Prevention awarded a $999,961 Cooperative Agreement to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) on September 30, 2025, under the Assistance Programs for Chronic Disease Prevention and Control program (CFDA 93.945). The award funds DYNAMO—Diabetes in Youth and Young Adults of the Pacific Northwest, a multi-site study examining diabetes in youth and young adults across the Pacific Northwest region.

The recipient organization coordinates study protocol development, dataset analysis and interpretation, and manuscript preparation across multiple clinical sites. Work is performed in Washington. The period of performance runs through September 29, 2027.

Three sub-grantees deliver site-specific research coordination and clinical leadership. The University of Washington, with Dr. Laura Pyle serving as Multi-PI, leads the UW team in protocol development, data analysis, and study dissemination. Providence Health & Services-Washington, under site PI Dr. Katherine Tuttle, contributes to protocol implementation, data interpretation, and manuscript development at the local site level. Seattle Institute for Biomedical and Clinical Research, led by site PI Dr. Pandora Luke Wander, provides research coordination and analytical support. Each sub-grantee participates in project meetings, contributes to publications, and disseminates findings in collaboration with Lead PIs Drs. Catherine Pihoker and Laura Pyle.